Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. The company's technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was founded in 2003 and is headquartered in Santa Monica, California.
IPO Year:
Exchange: NASDAQ
Website: ontrak-inc.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/5/2023 | $4.00 | Buy | ROTH MKM |
| 3/9/2022 | $13.00 → $2.50 | Hold | Canaccord Genuity |
| 3/9/2022 | $11.00 → $2.00 | Sector Perform | RBC Capital |
| 8/20/2021 | $35.00 → $9.00 | Market Perform → Underperform | Cowen & Co. |
| 8/20/2021 | $15.00 | Buy → Neutral | B. Riley Securities |
Q3 Revenue of $2.6 million, down 31% year-over-year Q3 Operating loss of $(5.1) million, a 26% increase year-over-year Q3 Adjusted EBITDA of $(3.3) million, a 24% decline year-over-year Company announces expansion of behavioral health solutions with Sentara Health for Commercial and Marketplace members Company begins enrollment of new members into Ontrak's WholeHealth+ solution under a new contract with a large northeast regional health plan and announces expansion of its services with Ontrak Quality solution Company announces a reverse split of its common stock at a ratio of 1-for-15, which was effective at 12:01 a.m. Eastern Time on September 23, 2024 Company to Host Co
Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes
Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and tech-enabled behavioral healthcare company, today announced an expansion of its strategic partnership with its most recently signed customer, a large, regional health plan in the Northeast. The expanded engagement uses Ontrak Health's recently launched Ontrak Quality solution to focus on behavioral health metrics according to Healthcare Effectiveness Data and Information Set (HEDIS). The goals are to enhance patient outcomes and help the health plan achieve national quality benchmarks. Ontrak Quality will broaden access to services for Commercial, Medicaid and HARP members not enrolled in the WholeHealth+ program, identified by the healt
Shares Expected to Begin Trading on Split-Adjusted Basis on September 23, 2024 Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, today announced that it will implement a 1-for-15 reverse split of the issued shares of its common stock, effective at 12:01 a.m. Eastern Time on September 23, 2024. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on September 23, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol "OTRK." The new CUSIP number for the common stock will be 683373 401. The reverse stock split is intended to increase the bid price of the common sto
Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announced significant findings from the first two-quarters of data collected through its implementation of the Recovering Quality of Life (ReQoL) measure. This patient-reported outcome measure (PROM) assesses the quality of life for individuals with various mental health conditions. The ReQoL assessment, now a standard component of Ontrak's clinical model, has provided valuable insights into factors impacting mental health across diverse populations. ReQoL assessments are intended to evaluate the impact of mental health conditions, psychological interventions, and healthcare interventions
Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announced that its Chief Innovation Officer, Brianna Brennan, will be a featured speaker at two influential healthcare events on September 25, 2024. Becker's Healthcare Webinar Ms. Brennan will present at the Becker's Healthcare Webinar, "Beyond the Numbers: How Holistic Member Journeys Drive Health Plan ROI," at 12:30 PM ET. This virtual event will focus on how health plans can leverage integrated data and holistic approaches to improve member outcomes and reduce costs. Key topics include: Maximizing value-based care models and improving member satisfaction Creating a 360-degree vi
Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, today announced the launch of Ontrak Quality, its latest product offering designed to help healthcare payers, providers, and stakeholders close gaps in care, thereby improving quality measures and ultimately quality scores. Quality scores play a vital role in shaping the healthcare landscape, impacting reimbursement rates, star ratings, and patient outcomes. This latest innovation continues Ontrak's expansion of their Advanced Engagement System to solve healthcare organizations' toughest problems. Ontrak Health's new product offering provides a comprehensive solution to identify, manage,
Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announced it has partnered with MosaicVoice, a pioneer in AI-powered voice technology, to transform healthcare delivery and patient outcomes for Ontrak and its members. The strategic partnership aims to create a more connected, intelligent, and patient-centric healthcare ecosystem by integrating advanced voice and AI technologies. "By partnering with MosaicVoice, we are combining the best in AI-driven engagement with our expertise in healthcare to deliver more effective and efficient care," said Brianna Brennan, Chief Innovation Officer at Ontrak Health. "This collaboration promotes a sc
Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and telehealth-enabled behavioral healthcare company, announced the achievement of the HITRUST Risk-based, 2-year (r2) certification of the customer data exchange elements of its Ontrak Advanced Engagement System. This certification underscores Ontrak's unwavering commitment to maintaining the highest standards of data security and regulatory compliance. The HITRUST CSF certification for Ontrak's Advanced Engagement System not only exemplifies our commitment to the gold standard in data protection and compliance but also ensures that our Ontrak Identify product suite, a core component of its WholeHealth+ solution, operates at the forefront
Q2 Revenue of $2.5 million, down 17% year over year Q2 Operating loss of $(4.0) million, a 13% improvement year over year Q2 Adjusted EBITDA of $(3.3) million, an 8% decline year over year Company announces new contract with large northeast regional health plan Company announces final results of a formal evaluation showing achievement of $721 per member per month cost savings for a prominent health plan's members Company announced the adoption of the Comprehensive Healthcare Integration (CHI) framework into its care delivery model Company to Host Conference Call at 4:30 pm ET Today Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technol
10-Q - Ontrak, Inc. (0001136174) (Filer)
8-K - Ontrak, Inc. (0001136174) (Filer)
8-K - Ontrak, Inc. (0001136174) (Filer)
EFFECT - Ontrak, Inc. (0001136174) (Filer)
424B5 - Ontrak, Inc. (0001136174) (Filer)
S-1 - Ontrak, Inc. (0001136174) (Filer)
8-K - Ontrak, Inc. (0001136174) (Filer)
8-K - Ontrak, Inc. (0001136174) (Filer)
8-K - Ontrak, Inc. (0001136174) (Filer)
S-8 - Ontrak, Inc. (0001136174) (Filer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
3 - Ontrak, Inc. (0001136174) (Issuer)
SC 13G/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13G - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
ROTH MKM initiated coverage of Ontrak with a rating of Buy and set a new price target of $4.00
Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $2.50 from $13.00 previously
RBC Capital reiterated coverage of Ontrak with a rating of Sector Perform and set a new price target of $2.00 from $11.00 previously
Cowen & Co. downgraded Ontrak from Market Perform to Underperform and set a new price target of $9.00 from $35.00 previously
B. Riley Securities downgraded Ontrak from Buy to Neutral and set a new price target of $15.00
Canaccord Genuity upgraded Ontrak from Hold to Buy and set a new price target of $46.00 from $32.00 previously
Canaccord Genuity upgraded Ontrak from Hold to Buy
Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $32.00 from $30.00 previously
Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $32.00 from $30.00 previously
Royal Bank of Canada resumed coverage of Ontrak with a rating of Sector Perform and set a new price target of $32.00 from $82.00 previously
Q3 Revenue of $2.6 million, down 31% year-over-year Q3 Operating loss of $(5.1) million, a 26% increase year-over-year Q3 Adjusted EBITDA of $(3.3) million, a 24% decline year-over-year Company announces expansion of behavioral health solutions with Sentara Health for Commercial and Marketplace members Company begins enrollment of new members into Ontrak's WholeHealth+ solution under a new contract with a large northeast regional health plan and announces expansion of its services with Ontrak Quality solution Company announces a reverse split of its common stock at a ratio of 1-for-15, which was effective at 12:01 a.m. Eastern Time on September 23, 2024 Company to Host Co
Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes
Q2 Revenue of $2.5 million, down 17% year over year Q2 Operating loss of $(4.0) million, a 13% improvement year over year Q2 Adjusted EBITDA of $(3.3) million, an 8% decline year over year Company announces new contract with large northeast regional health plan Company announces final results of a formal evaluation showing achievement of $721 per member per month cost savings for a prominent health plan's members Company announced the adoption of the Comprehensive Healthcare Integration (CHI) framework into its care delivery model Company to Host Conference Call at 4:30 pm ET Today Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technol
Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the second quarter 2024 on Thursday, August 8, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes b
Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the first quarter 2024 on Tuesday, May 14, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes befor
Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the fourth quarter 2024 on Tuesday, April 16, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes bef
Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2023 on Tuesday, November 14, 2023, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events . Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes
Q2 Revenue of $3.0 million and Year to Date Revenue of $5.5 million Company announces signing of new customer agreement with a regional Medicaid health plan Company completes reverse stock split of its common stock at a ratio of 1:6 Company announces achievement of certification as a Credentials Verification Organization (CVO) by the National Committee for Quality Assurance (NCQA) Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today reported its financial results for the second quarter ended June 30, 2023. Management Commentary "We are encouraged by our new customer agreement and other positive develop
Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the second quarter 2023 on Wednesday, August 9, 2023, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events . Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes
Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today reported its financial results for the first quarter ended March 31, 2023. Management Commentary "We continue to be encouraged by market feedback to our new modularized WholeHealth set of solutions. This, coupled with improved cost controls and new expansion with existing customers, have us on good footing as we work hard to sign new customers and serve more members in need of our innovative behavioral health care offerings," commented Chief Executive Officer, Brandon LaVerne. First Quarter 2023 Financial Results Highlights Revenue for the first quarter of 2
Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of James Messina as a non-Executive Director to its board. Mr. Messina is a Co-Founder and General Partner of Seattle Hill Ventures and x4 Capital Partners, which invest in, and support, startup ventures by providing business development, marketing, operating and technology support. Previously, Mr. Messina was the Executive Vice President and Chief Operating Officer for Premera Blue Cross ("Premera"). He was responsible for effectively servicing the needs of Premera's customers with oversight of all operational functions, from customer serv
Mental Healthcare Leader and Harvard Medical School Faculty Member Joins Ontrak Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Dr. Robert Accordino as Ontrak's Chief Medical Officer, effective September 27, 2021. Dr. Accordino joins Ontrak from Quartet Health where he served as the company's most senior clinician and Chief Mental Health Officer. He practices psychiatry and is on the faculty of Harvard Medical School and Massachusetts General Hospital. Dr. Accordino will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "Dr. Accordino's reputation in
Former Accenture and KPMG Healthcare Expert Brings Proven Leadership Experience In Behavioral Health Digital Transformation Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Arik Hill as Ontrak's first Chief Information Officer, effective August 30, 2021. Mr. Hill will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "As Chief Information Officer at The New York Foundling, a fast growing organization that collaborates with over 250,000 behavioral healthcare partners across the country, Arik led the development of digital platforms and applications th
Osborne brings proven track record of leadership in growth and expansions of multi-billion dollar government and commercial businesses at CVS Health, Aetna and Coventry Health Care Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of former CVS Health (NYSE:CVS) Regional Vice President and former President of Government business at Coventry Health Care Mary Louise Osborne as Ontrak's first Chief Customer Officer, effective August 30, 2021. Ms. Osborne will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS in April. "Mary Lou brings decades of progressive management experience and
SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today announced the appointment of CVS Health (NYSE: CVS) Executive Vice President and Chief Transformation Officer Jonathan Mayhew as Ontrak Chief Executive Officer effective April 12, 2021. Terren Peizer, who founded the company 17 years ago and served as CEO and Chairman through the company’s launch and expansion of national health plan contracts, was named Executive Chairman. Peizer will continue to serve as Chairman of the Ontrak Board of Directors and remains majority shareholder. “It’s been a tremendous
Ontrak, Inc (NASDAQ:OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announces the adoption of the Comprehensive Healthcare Integration (CHI) framework into its care delivery model. This advances Ontrak Health's commitment to delivering high quality, integrated, whole person care. The CHI model represents the most comprehensive clinical framework for integrating physical health, behavioral health, and social determinants of health within care delivery.
Gainers Kineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday's after-market session. The company's market cap stands at $8.1 million. iSpecimen (NASDAQ:ISPC) stock moved upwards by 13.99% to $0.57. The market value of their outstanding shares is at $5.6 million. ENDRA Life Sciences (NASDAQ:NDRA) shares moved upwards by 11.0% to $0.12. The market value of their outstanding shares is at $1.9 million. Brainstorm Cell (NASDAQ:BCLI) shares increased by 9.08% to $0.51. The market value of their outstanding shares is at $35.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 7.53% to $2.71. The company's market cap stands at $21.2 million. Can Fite Biofarma (AMEX:
Gainers Lucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 123.5% to $1.14 during Thursday's pre-market session. The market value of their outstanding shares is at $2.0 million. SINTX Techs (NASDAQ:SINT) stock moved upwards by 19.67% to $0.15. The market value of their outstanding shares is at $18.7 million. As per the press release, Q1 earnings came out 3 days ago. Dynatronics (NASDAQ:DYNT) stock increased by 16.7% to $0.51. The market value of their outstanding shares is at $2.7 million. Ontrak (NASDAQ:OTRK) shares moved upwards by 15.99% to $0.31. The company's market cap stands at $14.8 million. The company's, Q1 earnings came out 2 days ago. NovaBay Pharmaceuticals (AME
Ontrak (NASDAQ:OTRK) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.19) by 47.37 percent. This is a 95.27 percent increase over losses of $(2.11) per share from the same period last year. The company reported quarterly sales of $2.68 million which missed the analyst consensus estimate of $2.70 million by 0.74 percent. This is a 5.97 percent increase over sales of $2.53 million the same period last year.
Gainers Agape ATP (NASDAQ:ATPC) shares rose 23.0% to $0.32 during Monday's after-market session. The market value of their outstanding shares is at $24.9 million. FibroGen (NASDAQ:FGEN) shares increased by 20.68% to $1.4. The market value of their outstanding shares is at $139.2 million. As per the news, the Q1 earnings report came out today. RxSight (NASDAQ:RXST) shares rose 11.39% to $70.0. The company's market cap stands at $2.6 billion. As per the news, the Q1 earnings report came out today. Innovative Eyewear (NASDAQ:LUCY) shares increased by 10.81% to $0.25. The market value of their outstanding shares is at $3.2 million. Hims & Hers Health (NYSE:HIMS) shares increased by 10.72% t
Gainers ImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. Nuwellis (NASDAQ:NUWE) shares increased by 24.1% to $0.41. The market value of their outstanding shares is at $2.8 million. VolitionRX (AMEX:VNRX) stock increased by 16.66% to $0.7. The company's market cap stands at $57.4 million. Tiziana Life Sciences (NASDAQ:TLSA) shares increased by 15.47% to $0.87. The market value of their outstanding shares is at $87.2 million. Ontrak (NASDAQ:OTRK) stock moved upwards by 14.46% to $0.34. The market value of their outstanding shares is at $16.1 million. NKGen Biotech (NASDAQ:NKGN) shares in
Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 67.1% to $5.42 during Thursday's regular session. The market value of their outstanding shares is at $4.0 million. Aileron Therapeutics (NASDAQ:ALRN) stock moved upwards by 53.88% to $6.54. The company's market cap stands at $111.0 million. As per the press release, Q4 earnings came out 3 days ago. 23andMe Holding (NASDAQ:ME) stock moved upwards by 45.48% to $0.52. The company's market cap stands at $250.2 million. SINTX Techs (NASDAQ:SINT) stock moved upwards by 40.75% to $0.05. The company's market cap stands at $6.4 million. iSpecimen (NASDAQ:ISPC) shares moved upwards by 33.19% to $0.28. The company's market cap stands at $
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21. The S&P 500 also fell, dropping, 0.34% to 5,034.17. Check This Out: Alphabet, Toll Brothers And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Utilities shares rose by 1.5% on Wednesday. In trading on Wednesday, information technology shares fell by 1.1%. Top Headline U.S. Bancorp (NYSE:USB) reported upbeat first-quarter FY24 earnings on Wednesday. Revenue stood at $6.7 billion (-6.4% Y/Y), which aligns with the consensus. Adjusted earnings per share came i